75 related articles for article (PubMed ID: 22233540)
1. Kinetic characterization of a slow-binding inhibitor of Bla2: thiomaltol.
Schlesinger SR; Bruner B; Farmer PJ; Kim SK
J Enzyme Inhib Med Chem; 2013 Feb; 28(1):137-42. PubMed ID: 22233540
[TBL] [Abstract][Full Text] [Related]
2. Purification development and characterization of the zinc-dependent metallo-β-lactamase from Bacillus anthracis.
Schlesinger SR; Kim SG; Lee JS; Kim SK
Biotechnol Lett; 2011 Jul; 33(7):1417-22. PubMed ID: 21369909
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Bacillus anthracis metallo-β-lactamase by compounds with hydroxamic acid functionality.
Kim SK; Demuth M; Schlesinger SR; Kim SJ; Urbanczyk J; Shaw RW; Shin H
J Enzyme Inhib Med Chem; 2016; 31(sup4):132-137. PubMed ID: 27557855
[TBL] [Abstract][Full Text] [Related]
4. Development of Hydroxamic Acid Compounds for Inhibition of Metallo-β-Lactamase from
Huckleby AE; Saul JG; Shin H; Desmarais S; Bokka A; Jeon J; Kim SK
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012433
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of penicillin-based inhibitors of the class A and B beta-lactamases from Bacillus anthracis.
Beharry Z; Chen H; Gadhachanda VR; Buynak JD; Palzkill T
Biochem Biophys Res Commun; 2004 Jan; 313(3):541-5. PubMed ID: 14697223
[TBL] [Abstract][Full Text] [Related]
6. The identification of new metallo-β-lactamase inhibitor leads from fragment-based screening.
Vella P; Hussein WM; Leung EW; Clayton D; Ollis DL; Mitić N; Schenk G; McGeary RP
Bioorg Med Chem Lett; 2011 Jun; 21(11):3282-5. PubMed ID: 21536436
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.
Materon IC; Queenan AM; Koehler TM; Bush K; Palzkill T
Antimicrob Agents Chemother; 2003 Jun; 47(6):2040-2. PubMed ID: 12760895
[TBL] [Abstract][Full Text] [Related]
8. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases.
Simm AM; Loveridge EJ; Crosby J; Avison MB; Walsh TR; Bennett PM
Biochem J; 2005 May; 387(Pt 3):585-90. PubMed ID: 15569001
[TBL] [Abstract][Full Text] [Related]
9. An insight into the complete biophysical and biochemical characterization of novel class A beta-lactamase (Bla1) from Bacillus anthracis.
Bhattacharya S; Junghare V; Pandey NK; Ghosh D; Patra H; Hazra S
Int J Biol Macromol; 2020 Feb; 145():510-526. PubMed ID: 31874266
[TBL] [Abstract][Full Text] [Related]
10. Differential binding of Co(II) and Zn(II) to metallo-beta-lactamase Bla2 from Bacillus anthracis.
Hawk MJ; Breece RM; Hajdin CE; Bender KM; Hu Z; Costello AL; Bennett B; Tierney DL; Crowder MW
J Am Chem Soc; 2009 Aug; 131(30):10753-62. PubMed ID: 19588962
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and kinetic testing of tetrahydropyrimidine-2-thione and pyrrole derivatives as inhibitors of the metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa.
Hussein WM; Fatahala SS; Mohamed ZM; McGeary RP; Schenk G; Ollis DL; Mohamed MS
Chem Biol Drug Des; 2012 Oct; 80(4):500-15. PubMed ID: 22738437
[TBL] [Abstract][Full Text] [Related]
12. Metallo-β-lactamase-catalyzed hydrolysis of cephalosporins: some mechanistic insights into the effect of heterocyclic thiones on enzyme activity.
Tamilselvi A; Mugesh G
Inorg Chem; 2011 Feb; 50(3):749-56. PubMed ID: 21210647
[TBL] [Abstract][Full Text] [Related]
13. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
Weston GS; Blázquez J; Baquero F; Shoichet BK
J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of peroxidase-catalyzed iodination by cephalosporins: Metallo-beta-lactamase-induced antithyroid activity of antibiotics.
Tamilselvi A; Mugesh G
ChemMedChem; 2009 Apr; 4(4):512-6. PubMed ID: 19107757
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of metallo-beta-lactamase by thioxo-cephalosporin derivatives.
Tsang WY; Dhanda A; Schofield CJ; Frère JM; Galleni M; Page MI
Bioorg Med Chem Lett; 2004 Apr; 14(7):1737-9. PubMed ID: 15026061
[TBL] [Abstract][Full Text] [Related]
16. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display.
Sanschagrin F; Levesque RC
J Antimicrob Chemother; 2005 Feb; 55(2):252-5. PubMed ID: 15659541
[TBL] [Abstract][Full Text] [Related]
17. 3-mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors.
Faridoon ; Hussein WM; Vella P; Islam NU; Ollis DL; Schenk G; McGeary RP
Bioorg Med Chem Lett; 2012 Jan; 22(1):380-6. PubMed ID: 22115595
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the design of inhibitors for the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia.
Nauton L; Kahn R; Garau G; Hernandez JF; Dideberg O
J Mol Biol; 2008 Jan; 375(1):257-69. PubMed ID: 17999929
[TBL] [Abstract][Full Text] [Related]
19. Novel IMP-1 metallo-beta-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1.
Moloughney JG; D Thomas J; Toney JH
FEMS Microbiol Lett; 2005 Feb; 243(1):65-71. PubMed ID: 15668002
[TBL] [Abstract][Full Text] [Related]
20. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-beta-lactamases.
Siemann S; Clarke AJ; Viswanatha T; Dmitrienko GI
Biochemistry; 2003 Feb; 42(6):1673-83. PubMed ID: 12578382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
